ADMA Biologics Inc (ADMA)

Debt-to-assets ratio

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Long-term debt US$ in thousands 72,337 130,594 142,833 94,866 92,969
Total assets US$ in thousands 488,678 329,182 348,461 276,253 207,673
Debt-to-assets ratio 0.15 0.40 0.41 0.34 0.45

December 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $72,337K ÷ $488,678K
= 0.15

The debt-to-assets ratio of ADMA Biologics Inc has exhibited a fluctuating trend over the past five years. Starting at 0.45 as of December 31, 2020, the ratio decreased to 0.34 by the end of 2021. Subsequently, it slightly increased to 0.41 in 2022 before dropping to 0.40 in 2023. Notably, there was a significant decline in the ratio to 0.15 by December 31, 2024, indicating a substantial reduction in the company's debt relative to its total assets. This suggests that ADMA Biologics Inc has become more efficient in managing its debt obligations and enhancing its financial stability by leveraging a lower proportion of debt in its capital structure.